Title : Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma.

Pub. Date : 2003 Sep 1

PMID : 12942567






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: In single center studies and case reports, it was shown that pegylated liposomal doxorubicin (PEG-DOXO) was effective as second-line therapy for patients with cutaneous T-cell lymphoma (CTCL). liposomal doxorubicin TSPY like 2 Homo sapiens
2 The objective of this study was to evaluate the efficacy and toxicity of single-agent PEG-DOXO as second-line chemotherapy in patients with CTCL. liposomal doxorubicin TSPY like 2 Homo sapiens
3 CONCLUSIONS: This multicenter study provided evidence of high efficacy of PEG-DOXO monotherapy with a low rate of severe adverse effects compared with other chemotherapy protocols in patients with CTCL. liposomal doxorubicin TSPY like 2 Homo sapiens